RenaissanceRe (NYSE:RNR - Get Free Report) had its price target lifted by analysts at Morgan Stanley from $335.00 to $365.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an "equal weight" rating on the insurance provider's stock. Morgan Stanley's price target suggests a potential upside of 3.39% from the stock's current price.
RNR has been the topic of several other research reports. UBS Group upped their price objective on RenaissanceRe from $349.00 to $366.00 and gave the stock a "neutral" rating in a research report on Monday, November 2nd. Bank of America raised their price objective on shares of RenaissanceRe from $410.00 to $438.00 and gave the stock a "buy" rating in a research note on Thursday, July 23rd. TD Cowen lifted their target price on shares of RenaissanceRe from $315.00 to $320.00 and gave the company a "hold" rating in a report on Monday, October 12th. Citigroup increased their price target on shares of RenaissanceRe from $370.00 to $385.00 and gave the stock a "buy" rating in a report on Thursday, October 29th. Finally, Weiss Ratings downgraded shares of RenaissanceRe from a "buy (b+)" rating to a "hold (c+)" rating in a report on Thursday, October 29th. Five equities research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, RenaissanceRe currently has a consensus rating of "Hold" and a consensus price target of $346.50.
View Our Latest Analysis on RenaissanceRe
RenaissanceRe Stock Performance
Shares of RNR stock traded down $3.57 on Tuesday, hitting $353.02. The company had a trading volume of 42,204 shares, compared to its average volume of 363,848. The firm has a market cap of $14.27 billion, a P/E ratio of 10.16, a price-to-earnings-growth ratio of 0.91 and a beta of 0.11. The company has a 50-day moving average price of $337.88 and a 200-day moving average price of $314.38. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 0.22. RenaissanceRe has a twelve month low of $251.60 and a twelve month high of $363.84.
RenaissanceRe (NYSE:RNR - Get Free Report) last posted its earnings results on Tuesday, October 27th. The insurance provider reported $12.71 EPS for the quarter, topping the consensus estimate of $10.56 by $2.15. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.78 billion. RenaissanceRe had a return on equity of 21.13% and a net margin of 16.25%. During the same period last year, the company earned $15.62 earnings per share. As a group, equities research analysts predict that RenaissanceRe will post 49.95 earnings per share for the current fiscal year.
Institutional Investors Weigh In On RenaissanceRe
Several institutional investors and hedge funds have recently added to or reduced their stakes in RNR. Aquatic Capital Management LLC purchased a new position in shares of RenaissanceRe in the third quarter worth about $414,000. Lighthouse Investment Partners LLC purchased a new stake in RenaissanceRe during the 3rd quarter valued at about $11,745,000. Toronto Dominion Bank purchased a new stake in RenaissanceRe during the 3rd quarter valued at about $2,646,000. Modern Wealth Management LLC purchased a new stake in RenaissanceRe during the 3rd quarter valued at about $235,000. Finally, EP Wealth Advisors LLC acquired a new stake in RenaissanceRe in the 3rd quarter valued at about $301,000. Institutional investors and hedge funds own 99.97% of the company's stock.
About RenaissanceRe
(
Get Free Report)
RenaissanceRe Holdings Ltd. is a Bermuda-based provider of reinsurance and insurance, serving clients around the world. The company focuses on helping insurers and other businesses manage risks that can be difficult to predict or absorb. Its main offerings include property catastrophe reinsurance, which helps protect insurers against losses from events such as hurricanes and earthquakes, as well as casualty and specialty reinsurance and insurance. RenaissanceRe also manages capital on behalf of third-party investors and uses risk modeling to assess and manage its exposure.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider RenaissanceRe, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RenaissanceRe wasn't on the list.
While RenaissanceRe currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.